Inhibition of neovascularization using VEGF-specific oligonucleotides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 20, 1998
Grant Date -
N/A
app pub date -
Jul 12, 1995
filing date -
Jul 27, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are methods of reducing neovascularization and of treating various disorders associated with neovascularization. These methods include administering to a tissue or subject a synthetic oligonucleotide specific for vascular endothelial growth factor nucleic acid effective in inhibiting the expression of vascular endothelial growth factor.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully